- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03084822
Cardiovascular Health Promotion Among African-Americans by FAITH! (FAITH!)
March 27, 2023 updated by: LaPrincess C. Brewer, Mayo Clinic
Cardiovascular Health Promotion Among African-Americans by FAITH! (Fostering African-American Improvement in Total Health): Engaging the Community Through Mobile Technology-assisted Education
Given the importance of healthy lifestyle practices to cardiovascular disease (CVD) prevention and the utility of church-based interventions in African-American adults, the investigators developed a theory-informed, strategically-planned, health and wellness intervention with Rochester, Minnesota (MN) and Twin Cities area (Minneapolis, St. Paul, MN) churches with predominately African-American congregations.
The objective of the study was to partner with churches to implement a multi-component, health education program through the use of core educational sessions delivered through a digital-application accessible on demand via interactive access on computer tablets and the Internet.
The overarching goal was to increase the awareness and critical importance of healthy lifestyles for CVD prevention and provide support for behavior change.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Basic Internet navigation skills, at least weekly Internet access, active email address, minimal fruit/vegetable intake (<5 servings/day), no regular physical activity program (< 30 minutes/d of moderate physical activity), able to engage in moderate physical activity (no restrictions)
Exclusion Criteria:
- Diagnosis of a serious medical condition or disability that would make participation difficult (i.e. visual or hearing impairment, mental disability that would preclude independent use of the app)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FAITH! App digital intervention
The digital app will include 10 education modules addressing the major CVD risk factors to be delivered on-demand through an innovative, interactive video series.
The digital app will also support the multi-media education modules, interactive surveys/quizzes, self-monitoring (diet, physical activity), and social networking (discussion board) functionality.
|
The digital app will include 10 education modules addressing the major CVD risk factors to be delivered on-demand through an innovative, interactive video series.
The digital app will also support the multi-media education modules, interactive surveys/quizzes, self-monitoring (diet, physical activity), and social networking (discussion board) functionality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diet (fruit/vegetable intake using adaptation of NIH Eating at America's Table Quick Food Scan Screener)
Time Frame: 28 weeks post-intervention
|
Change in self reported diet
|
28 weeks post-intervention
|
|
Physical activity behavior
Time Frame: 28 weeks post-intervention
|
Change in self-reported physical activity, reported as minutes per week of moderate to vigorous physical activity
|
28 weeks post-intervention
|
|
Diet self-efficacy (using Self-Efficacy and Eating Habits Survey)
Time Frame: 28 weeks post-intervention
|
Change from baseline self-efficacy; scale of 1-5; Healthy diet score components include the following: fruits and vegetables, ≥4.5 cups/d; fish, 2 or more 3.5-oz servings/wk; fiber-rich whole grains (≥1.1 g fiber/10 g carbohydrate), 3 or more 1-oz-equivalent servings/d; sodium, ≤1500 mg/d; and sugar-sweetened beverages, ≤450 kcal/wk.
Dietary recommendations are scaled according to a 2000-kcal/d diet.
|
28 weeks post-intervention
|
|
Physical activity self-efficacy (using Self-Efficacy and Exercise Habits Survey)
Time Frame: 28 weeks post-intervention
|
Change from baseline self-efficacy.
Physical activity is reported via the Self-Regulation Scale from Health Beliefs Survey, which includes 10 items, using a 5-point Likert scale (1=never to 5=always) with higher scores indicating higher PA self-regulation
|
28 weeks post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention feasibility
Time Frame: 28 weeks post-intervention
|
Participant retention (goal >80% of enrolled participants)
|
28 weeks post-intervention
|
|
BMI
Time Frame: 28 weeks post-intervention
|
Change from baseline BMI
|
28 weeks post-intervention
|
|
Blood Pressure
Time Frame: 28 weeks post-intervention
|
Change from baseline blood pressure
|
28 weeks post-intervention
|
|
Fasting Cholesterol
Time Frame: 28 weeks post-intervention
|
Change from baseline cholesterol
|
28 weeks post-intervention
|
|
Fasting glucose
Time Frame: 28 weeks post-intervention
|
Change from baseline fasting glucose
|
28 weeks post-intervention
|
|
Smoking (using adaptation of Global Adult Tobacco Survey)
Time Frame: 28 weeks post-intervention
|
Change in self reported smoking status
|
28 weeks post-intervention
|
|
Cardiovascular health knowledge
Time Frame: 28 weeks post-intervention
|
Change in percent correct from baseline knowledge and attitudes about CVD
|
28 weeks post-intervention
|
|
Life's Simple 7 Composite Score
Time Frame: 28 weeks post-intervention
|
Change from baseline Life's Simple 7 Composite Score; calculated as a composite of each LS7 component by assigning 2 points for ideal, 1 point for intermediate, or 0 points for poor.
The total composite score is assessed on a scale of 0 to 14 points.
To categorize, scores of 0 to 6 were labeled "poor', 7 to 8 "intermediate" and 9 to 14 "ideal" cardiovascular health.
|
28 weeks post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: LaPrincess C Brewer, MD, MPH, Mayo Clinic Department of Cardiovascular Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Brewer LC, Kumbamu A, Smith C, Jenkins S, Jones C, Hayes SN, Burke L, Cooper LA, Patten CA. A Cardiovascular Health and Wellness Mobile Health Intervention Among Church-Going African Americans: Formative Evaluation of the FAITH! App. JMIR Form Res. 2020 Nov 17;4(11):e21450. doi: 10.2196/21450.
- Brewer LC, Hayes SN, Caron AR, Derby DA, Breutzman NS, Wicks A, Raman J, Smith CM, Schaepe KS, Sheets RE, Jenkins SM, Lackore KA, Johnson J, Jones C, Radecki Breitkopf C, Cooper LA, Patten CA. Promoting cardiovascular health and wellness among African-Americans: Community participatory approach to design an innovative mobile-health intervention. PLoS One. 2019 Aug 20;14(8):e0218724. doi: 10.1371/journal.pone.0218724. eCollection 2019.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2016
Primary Completion (Actual)
June 1, 2017
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
March 1, 2017
First Submitted That Met QC Criteria
March 14, 2017
First Posted (Actual)
March 21, 2017
Study Record Updates
Last Update Posted (Actual)
March 29, 2023
Last Update Submitted That Met QC Criteria
March 27, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-000353
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on FAITH! App digital intervention
-
Mayo ClinicJohns Hopkins University; National Institute on Minority Health and Health... and other collaboratorsRecruiting
-
Mayo ClinicCompletedHigh Blood PressureUnited States
-
Mayo ClinicMiami Heart Research Institute Inc.RecruitingHypertensionUnited States
-
University of Texas Southwestern Medical CenterCompletedHypertension | Obesity | Cardiovascular Disease | DiabetesUnited States
-
TakedaCompleted
-
University Medical Center GroningenCompleted
-
Massachusetts General HospitalAmerican Cancer Society, Inc.RecruitingPhysical Function | Advanced Lung CancerUnited States
-
Emory UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
University of South CarolinaCompletedPhysical Activity, Healthy EatingUnited States
-
The University of Hong KongRecruiting